{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:50:02Z","timestamp":1759009802109},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2004,1,1]]},"DOI":"10.1038\/sj.bmt.1704335","type":"journal-article","created":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T08:10:03Z","timestamp":1070266203000},"page":"183-187","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation"],"prefix":"10.1038","volume":"33","author":[{"given":"J A","family":"P\u00e9rez-Sim\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Garc\u00eda-Escobar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Ca\u00f1izo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M V","family":"Mateos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J F","family":"San Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,12,1]]},"reference":[{"key":"BF1704335_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7326\/0003-4819-123-3-199508010-00008","volume":"123","author":"MD Feroze Momin","year":"1995","unstructured":"Feroze Momin MD, Pranatharthi H, Chandrasekar MD . Antimicrobial prophylaxis in bone marrow transplantation. Ann Intern Med 1995; 123: 205\u2013215.","journal-title":"Ann Intern Med"},{"key":"BF1704335_CR2","first-page":"123","volume":"21","author":"JW van der Meer","year":"1984","unstructured":"van der Meer JW, Guiot HF, van der Broek PJ, van Furth R . Infections in bone marrow transplant recipients. Semin Hematol 1984; 21: 123\u2013140.","journal-title":"Semin Hematol"},{"key":"BF1704335_CR3","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1182\/blood.V80.10.2668.2668","volume":"80","author":"DW Beelen","year":"1992","unstructured":"Beelen DW, Haralambie E, Brandt H et al. Evidence that sustained growth supresion of intestinal anaerobic bacteria reduces the risk of acute graft versus host disease after sibling marrow transplantation. Blood 1992; 80: 2668\u20132676.","journal-title":"Blood"},{"key":"BF1704335_CR4","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/clinids\/11.Supplement_7.S1551","volume":"11","author":"PA Pizzo","year":"1989","unstructured":"Pizzo PA . Considerations for the prevention of the infectious complications in immunosuppressed patients with cancer. Rev Infect Dis 1989; 11: 1551\u20131563.","journal-title":"Rev Infect Dis"},{"key":"BF1704335_CR5","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/1097-0142(19900515)65:10<2185::AID-CNCR2820651005>3.0.CO;2-4","volume":"65","author":"D Metcalf","year":"1990","unstructured":"Metcalf D . The colony stimulating factors: discovery, development, and clinical applications. Cancer 1990; 65: 1286\u20131295.","journal-title":"Cancer"},{"key":"BF1704335_CR6","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJM199106203242504","volume":"324","author":"J Nemunaitis","year":"1991","unstructured":"Nemunaitis J, Rabinowe SN, Singer JW et al. Recombinant granulocyte\u2013macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 1991; 324: 1773\u20131778.","journal-title":"N Engl J Med"},{"key":"BF1704335_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.7326\/0003-4819-116-3-183","volume":"116","author":"R Advani","year":"1992","unstructured":"Advani R, Chao NJ, Horning SJ et al. Granulocyte\u2013macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hematopoietic stem cell transplantation for lymphoma. Ann Intern Med 1992; 116: 183\u2013189.","journal-title":"Ann Intern Med"},{"key":"BF1704335_CR8","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/0140-6736(90)93111-2","volume":"336","author":"R Powles","year":"1990","unstructured":"Powles R, Smith C, Milan S et al. Human recombinant GM-CSF in allogeneic bone marrow transplantation for leukemia: double-blind, placebo-controlled trial. Lancet 1990; 336: 1417\u20131420.","journal-title":"Lancet"},{"key":"BF1704335_CR9","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1200\/JCO.1998.16.3.1179","volume":"16","author":"AE Eric","year":"1998","unstructured":"Eric AE, Joseph L, Michael B . Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. J Clin Oncol 1998; 16: 1179\u20131187.","journal-title":"J Clin Oncol"},{"key":"BF1704335_CR10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/00007890-199103000-00017","volume":"51","author":"MA Lew","year":"1991","unstructured":"Lew MA, Kehoe K, Ritz J et al. Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation. Transplantation 1991; 51: 630\u2013636.","journal-title":"Transplantation"},{"key":"BF1704335_CR11","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/0959-8049(93)90011-4","volume":"29","author":"AG Maiche","year":"1993","unstructured":"Maiche AG, Muhonen T . Granulocyte colony-stimulating factor (G-CSF) with or without a quinolone in the prevention of infection in cancer patients. Eur J Cancer 1993; 29: 1403\u20131405.","journal-title":"Eur J Cancer"},{"key":"BF1704335_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-106-1-1","volume":"106","author":"JE Karp","year":"1987","unstructured":"Karp JE, Merz WG, Hendricksen C et al. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1987; 106: 1\u20137.","journal-title":"Ann Intern Med"},{"key":"BF1704335_CR13","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/0002-9343(88)90062-9","volume":"84","author":"EJ Bow","year":"1988","unstructured":"Bow EJ, Rayner E, Louie TJ . Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis. Am J Med 1988; 84: 847\u2013854.","journal-title":"Am J Med"},{"key":"BF1704335_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF01646878","volume":"17","author":"M Cruciani","year":"1989","unstructured":"Cruciani M, Concia E, Navarra A et al. Prophylactic cotrimoxazole versus norfloxacin in neutropenic children \u2013 perspective ramdomized study. Infection 1989; 17: 65\u201369.","journal-title":"Infection"},{"key":"BF1704335_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1200\/JCO.1995.13.1.239","volume":"13","author":"MA Lew","year":"1995","unstructured":"Lew MA, Kehoe K, Ritz J et al. Ciprofloxacin versus trimethopim\/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial. J Clin Oncol 1995; 13: 239\u2013250.","journal-title":"J Clin Oncol"},{"key":"BF1704335_CR16","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/sj.bmt.1702043","volume":"24","author":"SP Yeh","year":"1999","unstructured":"Yeh SP, Hsueh EJ, Yu MS, Wang YC . Oral ciprofloxacin as antibacterial prophylaxis after allogeneic bone marrow transplantation: a reappraisal. Bone Marrow Transplant 1999; 24: 1207\u20131211.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704335_CR17","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1056\/NEJM199404283301717","volume":"330","author":"A Cometta","year":"1994","unstructured":"Cometta A, Calandra T, Bille J, Glauser MP . Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. N Engl J Med 1994; 330: 1240\u20131241.","journal-title":"N Engl J Med"},{"key":"BF1704335_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/clinids\/20.3.557","volume":"20","author":"J Carratal\u00e1","year":"1995","unstructured":"Carratal\u00e1 J, Fern\u00e1ndez-Sevilla A, Tubau F et al. Emergence of quinolone resistant Escherichia coli bacteriemia in neutropenic patients with cancer who have received prophylactic norfloxacin. Clin Infect Dis 1995; 20: 557\u2013560.","journal-title":"Clin Infect Dis"},{"key":"BF1704335_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/infdis\/161.1.41","volume":"16","author":"P Kotilainen","year":"1990","unstructured":"Kotilainen P, Nikoskelainen J, Huovinen P . Emergence if ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. J Infect Dis 1990; 16: 41\u201344.","journal-title":"J Infect Dis"},{"key":"BF1704335_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/BF01982191","volume":"13","author":"WV Kern","year":"1994","unstructured":"Kern WV, Markus A, Andriof E . Bacteriemia due to fluoro-quinolone-resistant Escherichia coli in two immunocompromised patients. Eur J Clin Microbiol Infect Dis 1994; 13: 161\u2013165.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"BF1704335_CR21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1128\/AAC.38.4.681","volume":"38","author":"WV Kern","year":"1994","unstructured":"Kern WV, Andriof E, Oethinger M et al. Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Antimicrob Agents Chemother 1994; 38: 681\u2013687.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF1704335_CR22","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/jac\/32.4.605","volume":"32","author":"T Alarc\u00f3n","year":"1993","unstructured":"Alarc\u00f3n T, Pita J, L\u00f3pez-Brea M, Piddock LJ . High-level quinolone resistance amongst clinical isolates of Escherichia coli and Klebsiella pneumoniae from Spain. J Antimicrob Chemother 1993; 32: 605\u2013609.","journal-title":"J Antimicrob Chemother"},{"key":"BF1704335_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0732-8893(97)00216-2","volume":"30","author":"J Ena","year":"1998","unstructured":"Ena J, L\u00f3pez-Perezagua MM, Martinez-Peinado C et al. Emergence of ciprofloxacin res\u00edstanse in Escherichia coli isolates after widespread use of fluoroquinolones. Diagn Microbiol Infect Dis 1998; 30: 103\u2013107.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"BF1704335_CR24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3109\/00365548809035663","volume":"20","author":"T Schmeisser","year":"1988","unstructured":"Schmeisser T, Kurrle E, Arnold R et al. Norfloxacin for the prevention of bacterial infection during severe granulocyto-penia after bone marrow transplantation. Scand J Infect Dis 1988; 20: 625\u2013631.","journal-title":"Scand J Infect Dis"},{"key":"BF1704335_CR25","first-page":"489","volume":"4","author":"F Menichetti","year":"1989","unstructured":"Menichetti F, Felicini R, Bucaneve G et al. Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplant 1989; 4: 489\u2013492.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704335_CR26","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/00007890-199103000-00017","volume":"51","author":"MA Lew","year":"1991","unstructured":"Lew MA, Kehoe K, Ritz J et al. Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation. Transplantation 1991; 51: 630\u2013636.","journal-title":"Transplantation"},{"key":"BF1704335_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1034\/j.1399-3062.2002.t01-1-01014.x","volume":"4","author":"F Krochinsky","year":"2002","unstructured":"Krochinsky F, Wichmann G, Bornhauser M et al. Efficacy and tolerability of prophylaxic treatment with intravenous piperacillin\/tazobactam in patients undergoing hematopoietic stem cell transplantation. Transplant Infect Dis 2002; 4: 132\u2013136.","journal-title":"Transplant Infect Dis"},{"key":"BF1704335_CR28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/0002-9343(90)90373-L","volume":"89","author":"DC Classen","year":"1990","unstructured":"Classen DC, Burke JP, Ford CD et al. Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis. Am J Med 1990; 89: 441\u2013446.","journal-title":"Am J Med"},{"key":"BF1704335_CR29","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/bmj.299.6694.294","volume":"299","author":"BA Oppenheim","year":"1989","unstructured":"Oppenheim BA, Hartley JW, Lee W, Burnie JP . Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukemia unit. BMJ 1989; 299: 294\u2013297.","journal-title":"BMJ"},{"key":"BF1704335_CR30","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1128\/AAC.38.3.576","volume":"38","author":"ER Broun","year":"1994","unstructured":"Broun ER, Wheat JL, Kneebone PH et al. Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation. Antimicrob Agents Chemother 1994; 38: 576\u2013579.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF1704335_CR31","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/AAC.38.3.465","volume":"38","author":"WV Kern","year":"1994","unstructured":"Kern WV, Hay B, Kern P et al. A randomized trial of reoxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis. Antimicrob Agents Chemother 1994; 38: 465\u2013472.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF1704335_CR32","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/BF01973990","volume":"13","author":"HFL Guiot","year":"1994","unstructured":"Guiot HFL, Corel LJA, Bossen JMHJ . Prevalence of penicillin-resistant viridians streptococci in healthy children and in patients with malignant haematological disorders. Eur J Clin Microbiol Infect Dis 1994; 13: 645\u2013650.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"BF1704335_CR33","first-page":"296","volume":"75","author":"E Orlandi","year":"1990","unstructured":"Orlandi E, Navarra A, Cruciani M et al. Norfloxacin versus cotrimoxazole for infection prophylaxis in granulocytopenic patients with acute leukemia. A prospective randomized study. Haematologica 1990; 75: 296\u2013298.","journal-title":"Haematologica"},{"key":"BF1704335_CR34","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1086\/513766","volume":"25","author":"DM Shales","year":"1997","unstructured":"Shales DM, Gerding DN, John JF et al. Society for healthcare epidemiology of America and infectious diseases society of America joint committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997; 25: 584\u2013599.","journal-title":"Clin Infect Dis"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704335","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704335.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704335.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:58:05Z","timestamp":1648079885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,1]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,1,1]]}},"alternative-id":["BF1704335"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704335","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,1]]},"assertion":[{"value":"4 April 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}